Drawing for RARE REVOLUTION

USPTO serial 79354670

RARE REVOLUTION

Reviewed by CopyMark Law Group

Reg. 7497691Status 700Registered
Filing date
Status date
Registration date
Sep 10, 2024
Examiner
BROWN, TINA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RARE REVOLUTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable digital supplements and brochures all in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; downloadable publications in the nature of books, magazines and newsletters, all in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; downloadable magazines in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; downloadable books in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; downloadable application software, namely, content applications for accessing, viewing and sharing information in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; downloadable application software for mobile devices, namely, content applications for accessing, viewing and sharing information in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; downloadable application software for wireless devices, namely, content applications for accessing, viewing and sharing information in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; audio books in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; downloadable computer software applications for accessing, viewing and sharing information in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; audio recordings in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; audio visual recordings in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregiversACTIVE
016Magazine covers, namely, book covers for magazines; magazine paper; printed magazine supplements for newspapers in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed magazines in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed brochures in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed periodical magazines in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed periodical publications, namely, magazines, newspapers and newsletters, in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed advertisements, namely, printed advertising posters and printed magazine advertisements featuring in a magazine; printed award certificates; printed awards; printed booklets in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed books in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed brochures in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed information sheets in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed informational flyers in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed informational sheets in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; printed leaflets in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregiversACTIVE
035Advertisement for others on the internet; placing of advertisements for others; preparing advertisements for others; advertising and advertisement services; advertising and marketing; advertising and marketing services; advertising and marketing services provided by means of blogging; advertising and marketing services provided via communications channels; advertising flyer distribution for others; advertising in periodicals, brochures and newspapers; advertising in the popular and professional press; advertising services to create corporate and brand identity; magazine advertising; marketing services; advertising; advertising and marketing services provided by means of social media; advertising services relating to pharmaceutical products; advertising services to promote public awareness of medical conditions; advertising services to promote public awareness of medical issues; arranging subscriptions to electronic journals; brand positioning services; advertising copywriting; copywriting for advertising and promotional purposes; direct market advertising; distribution of advertisements and commercial announcements; distribution of advertising announcements; distribution of advertising mail and of advertising supplements attached to regular editions; distribution of advertising, marketing and promotional material; distribution of advertising material; distribution of printed advertising matter; online advertising; on-line advertising and marketing services; providing advertising space, namely, providing and rental of advertising space on the Internet; providing advertising space in periodicals, newspapers and magazines; publication of advertising literature, namely, publishing of advertising texts; publication of printed matter for advertising purposes; publication of printed matter for advertising purposes in electronic form; provision and arranging of subscriptions to electronic journals for othersACTIVE
041Arranging and conducting of commercial, trade and business conferences in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging and conducting of educational events for charitable purposes, namely, colloquiums, conferences, congresses, seminars, symposiums, and workshops in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging and conducting of educational seminars in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging and conducting of entertainment events for charitable purposes, namely, social entertainment events, in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging and conducting of seminars in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging of an annual educational conference in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging of conferences in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; book publishing; publication of books; providing online non-downloadable electronic publications in the nature of magazines, books, brochures and newsletters, all in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; providing online electronic publications, not downloadable in the nature of magazines, books, brochures and newsletters, all in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; providing on-line non-downloadable electronic publications in the nature of magazines, books, brochures and newsletters, all in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging and conducting award ceremonies, namely, providing recognition and incentives by the way of awards to demonstrate excellence in the field of diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging and conducting conferences in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging and conducting conferences and seminars in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging and conducting educational conferences in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; arranging and conducting of in-person educational forums in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; conducting of educational seminars relating to medical matters; non-downloadable electronic online publication of periodicals and books in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; providing non-downloadable electronic publication in the nature of magazines, books, brochures and newsletters in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; electronic publishing services, namely, publishing of electronic publications; electronic publishing services for other, namely, publishing of electronic publications for others; magazine publishing; multimedia publishing of magazines, brochures, newsletters and electronic publications; multimedia publishing of books; multimedia publishing of electronic publications; multimedia publishing of journals; multimedia publishing of magazines; multimedia publishing of printed matter; online digital multimedia publishing services; online electronic publishing of books and periodicals; on-line publication of electronic books and journals; on-line publication of non-downloadable electronic books and journals in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; organisation of youth training schemes, namely, training and education services, namely, classes, workshops, colloquiums, conferences, congresses, seminars and symposiums in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; providing non-downloadable electronic publications in the nature of magazines, books, brochures and newsletters in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; publication and editing of printed matter; publication of audio books; publication of booklets; publication of books; publication of books, magazines, almanacs and journals; publication of brochures; publication of electronic books and journals online; publication of electronic books and periodicals on the internet; publication of electronic magazines; publication of journals; publication of leaflets; publication of magazines; publication of multimedia material online, namely, magazines, books, brochures and newsletters in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; publication of scientific information journals; publication of year books; book and magazine publishing; publishing of electronic publications; writing services for blogs, namely, writing articles for periodicals, magazines and journals, other than for advertising or publicity; written text editingACTIVE
044Providing medical information, advisory and analysis relating to the treatment of patients, and consultancy services relating to medical diagnosis, care, treatment and well-being of patients in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; providing medical information, advisory and analysis relating to the treatment of patients, and consultancy services relating to medical care and analysis services relating to patient treatment in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; providing medical information, advisory and analysis relating to the treatment of patients, and consultancy services for health care professionals and patients in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; providing medical information, advisory and analysis relating to the treatment of patients, and consultancy services relating to patient insights to capture their experiences, perspectives, needs and priorities in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; providing medical information, advisory and analysis relating to the treatment of patients, and consultancy services relating to patient insights directed at patients, families, caregivers, care partners, healthcare providers and patient advocacy groups in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; conducting patient surveys, namely, compilation, collation, and reporting of patient medical information, providing patient medical information in the form of reports, and the provision of health care services in the nature of providing a database in the field of patient medical information and featuring inputting and collection of data and information all for treatment and diagnostic purposes, in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; providing medical information, advisory and analysis relating to the treatment of patients, and consultancy services relating to the understanding of the impact on patients of their illnesses and their needs in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; compilation of medical reports and collation of medical information in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; information, advisory and consultancy services in relation to the aforesaid servicesACTIVE
045Information, advisory and consultancy services relating to personal and social services rendered to meet the needs of individuals diagnosed with or affected by rare diseases and related conditions, namely, the provision of information, advice and consultancy services in relation to personal support services for patients and families of patients, namely, companionship, help with medical forms, emotional counseling and emotional support; conducting personal background investigations to understand the diagnosis journey, natural history and quality of life impact of rare and chronic disease diagnosis on the individual and their family members in order to provide information to others, all in the field of rare diseases and related conditions, and those individuals diagnosed with or affected by rare diseases and related conditions, and their caregivers; providing case management services, namely, provision of non-medical information and advice in the field of personal lifestyle issues relating to the health of individuals; information, advisory and consultancy services in relation to the aforesaid servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 10, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 25, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 25, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 10, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 10, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 10, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 1, 2024GPNXNOTIFICATION PROCESSED BY IB
Jun 25, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 25, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 11, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 11, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 5, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 20, 2024XAECEXAMINER'S AMENDMENT ENTERED
May 20, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 20, 2024GNEAEXAMINERS AMENDMENT E-MAILED
May 20, 2024CNEAEXAMINERS AMENDMENT -WRITTEN
Apr 20, 2024GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Apr 20, 2024GNCFCONTINUATION OF FINAL REFUSAL E-MAILED
Apr 20, 2024CNCFACTION CONTINUING A FINAL - COMPLETED
Apr 15, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 9, 2024GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Mar 9, 2024GNCFCONTINUATION OF FINAL REFUSAL E-MAILED
Mar 9, 2024CNCFACTION CONTINUING A FINAL - COMPLETED
Feb 8, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 17, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Nov 17, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 17, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 1, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 31, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 31, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED
Oct 4, 2023RFNTREFUSAL PROCESSED BY IB
Sep 11, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2023CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Aug 28, 2023RFNTREFUSAL PROCESSED BY IB
Aug 22, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 22, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 22, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 22, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 4, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 31, 2023CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Jul 25, 2023RFRRREFUSAL PROCESSED BY MPU
Jun 19, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 18, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2023DOCKASSIGNED TO EXAMINER
Nov 18, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Nov 14, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 10, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance